| 000 | 01811 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250516015854.0 | ||
| 264 | 0 | _c20110127 | |
| 008 | 201101s 0 0 eng d | ||
| 022 | _a1460-2180 | ||
| 024 | 7 |
_a10.1093/carcin/bgq212 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLin, Cassie | |
| 245 | 0 | 0 |
_aInducible COX-2-dependent apoptosis in human ovarian cancer cells. _h[electronic resource] |
| 260 |
_bCarcinogenesis _cJan 2011 |
||
| 300 |
_a19-26 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aChromatin Immunoprecipitation |
| 650 | 0 | 4 |
_aCyclooxygenase 2 _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMicroscopy, Confocal |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinases _xdrug effects |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xmetabolism |
| 650 | 0 | 4 | _aProtein Transport |
| 650 | 0 | 4 | _aRNA, Small Interfering |
| 650 | 0 | 4 | _aResveratrol |
| 650 | 0 | 4 |
_aSUMO-1 Protein _xdrug effects |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aStilbenes _xpharmacology |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xdrug effects |
| 700 | 1 | _aCrawford, Dana R | |
| 700 | 1 | _aLin, Sharon | |
| 700 | 1 | _aHwang, Jualang | |
| 700 | 1 | _aSebuyira, Annette | |
| 700 | 1 | _aMeng, Ran | |
| 700 | 1 | _aWestfall, Jennifer E | |
| 700 | 1 | _aTang, Heng-Yuan | |
| 700 | 1 | _aLin, SuFan | |
| 700 | 1 | _aYu, Pin-Yung | |
| 700 | 1 | _aDavis, Paul J | |
| 700 | 1 | _aLin, Hung-Yun | |
| 773 | 0 |
_tCarcinogenesis _gvol. 32 _gno. 1 _gp. 19-26 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/carcin/bgq212 _zAvailable from publisher's website |
| 999 |
_c20474417 _d20474417 |
||